mitomycin has been researched along with nicardipine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hattori, M; Honda, T; Sampi, K | 1 |
1 review(s) available for mitomycin and nicardipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for mitomycin and nicardipine
| Article | Year |
|---|---|
[Combination therapy of vinca alkaloids and nicardipine in non-Hodgkin's lymphoma with resistant to various antineoplastic agents].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Drug Therapy, Combination; Female; Humans; Lymphoma; Male; Mitomycin; Mitomycins; Nicardipine; Nifedipine; Progesterone; Recurrence; Vinblastine; Vinca Alkaloids | 1983 |